Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient

被引：28

作者：

Benhadou, F. ^{[1
]}

del Marmol, V. ^{[1
]}

机构：

[1] Univ Libre Bruxelles, Dept Dermatol, Erasme Hosp, Brussels, Belgium

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2020年 / 34卷 / 08期

关键词：

COVID-19; EFFICACY; MODERATE; SAFETY;

D O I：

10.1111/jdv.16590

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E363 / E364

页数：2

共 7 条

[1] Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) [J].

Blauvelt, Andrew ;

Gooderham, Melinda ;

Iversen, Lars ;

Ball, Susan ;

Zhang, Lu ;

Agada, Noah O. ;

Reich, Kristian .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (05) :855-862

[2] Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial [J].

Blauvelt, Andrew ;

Papp, Kim A. ;

Griffiths, Christopher E. M. ;

Randazzo, Bruce ;

Wasfi, Yasmine ;

Shen, Yaung-Kaung ;

Li, Shu ;

Kimball, Alexa B. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (03) :405-417

[3] Reply to: "COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution'' [J].

Lebwohl, Mark ;

Rivera-Oyola, Ryan ;

Murrell, Dedee F. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) :E215-E215

[4] COVID-19: consider cytokine storm syndromes and immunosuppression [J].

Mehta, Puja ;

McAuley, Daniel F. ;

Brown, Michael ;

Sanchez, Emilie ;

Tattersall, Rachel S. ;

Manson, Jessica J. .

LANCET, 2020, 395 (10229) :1033-1034

[5] SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor [J].

Messina, F. ;

Piaserico, S. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) :E254-E255

[6] COVID-19: risk for cytokine targeting in chronic inflammatory diseases? [J].

Schett, Georg ;

Sticherling, Michael ;

Neurath, Markus F. .

NATURE REVIEWS IMMUNOLOGY, 2020, 20 (05) :271-272

[7] In the eye of the COVID-19 cytokine storm [J].

Vaninov N. .

Nature Reviews Immunology, 2020, 20 (5) :277-277

← 1 →